Stress-induced blood pressure elevation in subjects with mild cognitive impairment: Effects of the dual-type calcium channel blocker, cilnidipine

Geriatrics and Gerontology International

Volumn 8, Issue 4, 2008, Pages 278-283

  Kawashima, Yumiko ^a   Akishita, Masahiro ^b   Hasegawa, Hiroshi ^a   Kozaki, Koichi ^a   Toba, Kenji ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Calcium antagonists; Dementia; Hypertension; Mental stress

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CILNIDIPINE; DIHYDROPYRIDINE DERIVATIVE;

AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COGNITIVE DEFECT; HUMAN; HYPERTENSION; MENTAL STRESS; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIHYDROPYRIDINES; HUMANS; HYPERTENSION; STRESS, PSYCHOLOGICAL;

EID: 56849125841     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2008.00482.x     Document Type: Article

References (51)

1. Pickering TG. The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system. J Hum Hypertens 1997; 11(Suppl. 1): S9-S18.
2. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171-179.
3. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-2217.
4. Everson SA, McKey BS, Lovallo WR. The effect of trait hostility on cardiovascular responses to harassment in young men. Int J Behav Med 1995; 2: 172-191.
5. Kamarck TW, Peterman AH, Raynor DA. The effects of the social environment on stress-related cardiovascular activation: Current findings, prospects, and implications. Ann Behav Med 1998; 20: 247-256.
6. Smith TW, Christensen AJ. Cardiovascular reactivity and interpersonal relations: Psychosomatic processes in social context. J Soc Clin Psychol 1992; 11: 279-301.
7. Steptoe A, Cropley M, Joekes K. Job strain, blood pressure and response to uncontrollable stress. J Hypertens 1999; 17: 193-200.
8. Markovitz JH, Raczynski JM, Wallace D, Chettur V, Chesney MA. Cardiovascular reactivity to video game predicts subsequent blood pressure increases in young men: The CARDIA study. Psychosom Med 1998; 60: 186-191.
9. Carroll D, Smith GD, Sheffield D, Shipley MJ, Marmot MG. Pressor reactions to psychological stress and prediction of future blood pressure: Data from the Whitehall II Study. BMJ 1995; 310: 771-776.
10. Kamarck TW, Everson SA, Kaplan GA etal. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: Findings from the Kuopio Ischemic Heart Disease Study. Circulation 1997; 96: 3842-3848.
11. Barnett PA, Spence JD, Manuck SB, Jennings JR. Psychological stress and the progression of carotid artery disease. Hypertension 1997; 15: 49-55.
12. Nakashima T, Yamano S, Sasaki R etal. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res 2004; 27: 739-745.
13. Everson SA, Lynch JW, Kaplan GA, Lakka TA, Sivenius J, Salonen J. Stress-induced blood pressure reactivity and incident stroke in middle-aged men. Stroke 2001; 32: 1263-1270.
14. Waldstein SR, Siegel EL, Lefkowitz D et al. Stress-induced blood pressure reactivity and silent cerebrovascular disease. Stroke 2004; 35: 1294-1298.
15. Kanemaru A, Kanemaru K, Kuwajima I. The effects of short-time blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res 2001; 24: 19-24.
16. Muneta S, Dazai Y, Iwata T et al. Baroreceptor reflex impairment in climacteric and ovariectomized hypertensive women. Hypertens Res 1992; 15: 27-32.
17. Pierce TW, Elias MF. Cognitive function and cardiovascular responsivity in subjects with a parental history of hypertension. J Behav Med 1993; 16: 277-294.
18. Waldstein SR, Katzel LI. Stress-induced blood pressure reactivity and cognitive function. Neurology 2005; 64: 1746-1749.
19. Crowe M, Andel R, Wadley V etal. Subjective cognitive function and decline among older adults with psychometrically defined amnestic MCI. Int J Geriatr Psychiatry 2006; 21: 1187-1192.
20. Levinoff EJ, Phillips NA, Verret L et al. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment. Neuropsychology 2006; 20: 123-132.
21. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, Dekosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA 2002; 288: 1475-1483.
22. Bellelli G, Pezzini A, Bianchetti A, Trabucchi M. Increased blood pressure variability may be associated with cognitive decline in hypertensive elderly subjects with no dementia. Arch Intern Med 2002; 162: 483-484.
23. Murakami E, Matsuzaki K, Sumimoto T, Mukai M, Kazatani Y, Kodama K. Clinical significance of pressor responses to laboratory stressor testing in hypertension. Hypertens Res 1996; 133-137.
24. Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K. Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997; 280: 1184-1191.
25. Fujita T, Ando K, Nishimura H et al. Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Disease (CARTER) Study Investigators. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 2007; 72: 1543-1549.
26. Hirning LD, Fox AP, McCleskey EW et al. Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 1988; 239: 57-61.
27. Yamagishi T. Beneficial effect of cilnidipine on morning hypertension and white-coat effect in patients with essential hypertension. Hypertens Res 2006; 29: 339-344.
28. Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure. Hypertens Res 2005; 28: 1003-1008.
29. Morimoto S, Takeda K, Oguni A et al. Reduction of white coat effect by cilnidipine in essential hypertension. Am J Hypertens 2001; 10: 1053-1057.
30. Mansour G, Mansour J. Cilnidipine in management of patients with uncontrolled hypertension and white-coat effect. Curr Hypertens Rep 2007; 9: 489-490.
31. Lantelme P, Milon H, Gharib C, Gayet C, Fortrat JO. White coat effect and reactivity to stress: Cardiovascular and autonomic nervous system responses. Hypertension 1998; 31: 1021-1029.
32. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white coat effect. Hypertension 1997; 29: 1218-1224.
33. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998; 98: 1892-1897.
34. Mulè G, Nardi E, Cottone S et al. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension. Am J Hypertens 2003; 16: 498-501.
35. Amado P, Vasconcelos N, Santos I, Almeida L, NazaréJ, Carmona J. Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect". Rev Port Cardiol 1999; 18: 897-906.
36. Munakata M, Saito Y, Nunokawa T, Ito N, Fukudo S, Yoshinaga K. Clinical significance of blood pressure response triggered by a doctor's visit in patients with essential hypertension. Hypertens Res 2002; 25: 343-349.
37. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: Prospective cohort study. Eur Heart J 2000; 21: 1714-1718.
38. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145.
39. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y. Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 2003; 72: 1125-1133.
40. Kivipelto M, Helkala EL, Laakso MP et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 2001; 322: 1447-1451.
41. Sakurai T, Yokono K. Comprehensive studies of cognitive impairment of the elderly with type 2 diabetes. Geriatr Gerontol Int 2006; 6: 159-164.
42. Kim KI, Cho YS, Choi DJ, Kim CH. Optimal treatment of hypertension in the elderly: A Korean perspective. Geriatr Gerontol Int 2008; 8: 5-11.
43. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. Differential heart rate reactivity and recovery after psychosocial stress (TSST) in healthy children, younger adults, and elderly adults: the impact of age and gender. Int J Behav Med 2004; 11: 116-121.
44. Barnes RF, Raskind M, Gumbrecht G, Halter JB. The effects of age on the plasma catecholamine response to mental stress in man. J Clin Endocrinol Metab 1982; 54: 64-69.
45. Steptoe A, Fieldman G, Evans O, Perry L. Cardiovascular risk and responsivity to mental stress: The influence of age, gender and risk factors. J Cardiovasc Risk 1996; 3: 83-93.
46. Boutcher SH, Stocker D. Cardiovascular response of young and older males to mental challenge. J Gerontol B Psychol Sci Soc Sci 1996; 51: 261-267.
47. Yoshiuchi K, Nomura S, Ando K et al. Hemodynamic and endocrine responsiveness to mental arithmetic task and mirror drawing test in patients with essential hypertension. Am J Hypertens 1997; 10: 243-249.
48. Sawai A, Ohshige K, Yamasue K, Hayashi T, Tochikubo O. Influence of mental stress on cardiovascular function as evaluated by changes in energy expenditure. Hypertens Res 2007; 30: 1019-1027.
49. Hiramatsu R. Direct assay of cortisol in human saliva by solid phase radioimmunoassay and its clinical applications. Clin Chim Acta 1981; 117: 239-249.
50. Paran E, Neumann L, Cristal N. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment. Eur J Clin Pharmacol 1992; 43: 11-15.
51. Grossman E, Oren S, Garavaglia GE, Schmieder R, Messerli FH. Disparate hemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. Am J Cardiol 1989; 64: 42-44.